roche glp-1 drug Can Swiss pharma giant reshape the obesity market? Roche GLP-1 produces “robust” weight

Effect of alcohol on the central nervous system to develop neurological disorder: pathophysiological and lifestyle modulation can be potential therapeutic options for alcohol-induced neurotoxication

It may have stopped working because your skin did

This article explores evidence-based approaches to managing fatigue during GLP-1 therapy whilst ensuring safe, effective treatment outcomes

Download Full Fact Sheet Suggested Use 1 capsule per day or as recommended by your health care professional

Moreover, the Systolic Blood Pressure Intervention Trial (SPRINT) showed that prevalent users of Ang-II stimulating AHMs had a 25% lower risk of mild cognitive impairment or probable dementia compared to users of Ang-II inhibiting AHMs 12

Kojian and his team take a measured approach, starting at a lower dose and adjusting as needed